Induction of transgene-specific immunological tolerance in myeloablated nonhuman primates using lentivirally transduced CD34+ progenitor cells

Molecular Therapy

Volumn 8, Issue 6, 2003, Pages 981-991

  Kung, Sam K P ^a   An, Dong Sung ^a   Bonifacino, Aylin ^b   Metzger, Mark E ^b   Ringpis, Gene Errol ^a   Mao, Si Hua ^a   Chen, Irvin S Y ^a   Donahue, Robert E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Gene therapy; Lentiviral vectors; Transplantation

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL LINEAGE; CELL POPULATION; CONTROLLED STUDY; CPG ISLAND; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSDUCTION; HEMATOLOGIC MALIGNANCY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIMATE; PROTEIN PURIFICATION; STEM CELL MOBILIZATION; T LYMPHOCYTE ACTIVATION; TRANSGENE;

ANIMALIA; LENTIVIRUS; MACACA; MACACA MULATTA; PRIMATES;

EID: 0346656767     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2003.08.020     Document Type: Article

References (45)

1. Amado, R. G., and Chen, I. S. (1999). Lentiviral vectors-the promise of gene therapy within reach? Science 285: 674-676.
2. Cavazzana-Calvo, M., et al. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288: 669-672.
3. Aubert, D., et al. (2002). Cytotoxic immune response blunts long-term transgene expression after efficient retroviral-mediated hepatic gene transfer in rat. Mol. Ther. 5: 388-396.
4. Riddell, S. R., et al. (1996). T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat. Med. 2: 216-223.
5. Bordignon, C., et al. (1989). Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells. Proc. Natl. Acad. Sci. USA 86: 6748-6752.
6. Liberatore, C., et al. (1999). Natural killer cell-mediated lysis of autologous cells modified by gene therapy. J. Exp. Med. 189: 1855-1862.
7. Weissman, I. L., Anderson, D. J., and Gage, F. (2001). Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu. Rev. Cell Dev. Biol. 17: 387-403.
8. + bone marrow cells. Blood 82: 1975-1980.
9. Lim, B., Apperley, J. F., Orkin, S. H., and Williams, D. A. (1989). Long-term expression of human adenosine deaminase in mice transplanted with retrovirus-infected hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 86: 8892-8896.
10. Van Beusechem, V. W., Kukler, A., Heidt, P. J., and Valerio, D. (1996). Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. Proc. Natl. Acad. Sci. USA 89: 7640-7644.
11. Ally, B. A., et al. (1995). Prevention of autoimmune disease by retroviral-mediated gene therapy. J. Immunol. 155: 5404-5408.
12. Evans, G. L., and Morgan, R. A. (1998). Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A. Proc. Natl. Acad. Sci. USA 95: 5734-5739.
13. Heim, D. A., et al. (2000). Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model. Mol. Ther. 1: 533-544.
14. Lutzko, C., et al. (1999). Gene therapy for canine alpha-I-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease. Hum. Gene Ther. 10: 1521-1532.
15. Rosenzweig, M., et al. (2001). Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells. Blood 97: 1951-1959.
16. An, D. S., et al. (2000). Marking and gene expression by a lentivirUs vector in transplanted human and nonhuman primate CD34(+) cells. J. Virol. 74: 1286-1295.
17. Sutton, R. E., Wu, H. T., Rigg, R., Bohnlein, E., and Brown, P. O. (1998). Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. J. Virol. 72: 5781-5788.
18. Case, S. S., et al. (1999). Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc, Natl. Acad. Sci. USA 96: 2988-2993.
19. Naldini, L. (1998). Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr. Opin. Biotechnol. 9: 457-463.
20. Donahue, R. E., et al. (2000). High levels of lymphoid expression of enhanced green fluorescent protein in nonhuman primates transplanted with cytokine-mobilized peripheral blood CD34(+) cells. Blood 95: 445-452.
21. Dunbar, C. E., et al. (1995). Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85: 3048-3057.
22. An, D. S., et al. (2001). Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gamma-chain cytokine receptor in rhesus macaques. J. Virol. 75: 3547-3555.
23. Stripecke, R., et al. (1999). Immune response to green fluorescent protein: implications for gene therapy. Gene Ther. 6: 1305-1312.
24. Kung, S. K., An, D. S., and Chen, I. S. (2000). A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes. J. Virol. 74: 3668-3681.
25. Hartmann, G., Weiner, G. J., and Krieg, A. M. (1999). CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA 96: 9305-9310.
26. Klinman, D. M., Yi, A. K., Beaucage, S. L., Conover, J., and Krieg, A. M. (1996). CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl. Acad. Sci. USA 93: 2879-2883.
27. Krieg, A. M., et al. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546-549.
28. Chu, R. S., Targoni, O. S., Krieg, A. M., Lehmann, P. V., and Harding, C. V. (1997). CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186: 1623-1631.
29. Davis, H. L., et al. (1998). CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160: 870-876.
30. Hartmann, G., et al. (2000). Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164: 1617-1624.
31. Jones, T. R., et al. (1999). Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys. Vaccine 17: 3065-3071.
32. Horner, A. A., et al. (2001). Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites. J. Immunol. 167: 1584-1591.
33. Villinger, F,, et al. (2001 ). Chronic immune stimulation accelerates SIV-induced disease progression. J. Med. Primatol. 30: 254-259.
34. Sykes, M., et al. (1993). Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene. Transplantation 55: 197-202.
35. Schumacher, I. K., et al. (1996). Use of gene therapy to suppress the antigen-specific immune responses in mice to an HLA antigen. Transplantation 62: 831-836.
36. Zambidis, E. T., Kurup, A., and Scott, D. W. (1997). Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytes. Mol. Med. 3: 212-224.
37. Donahue, R. E., and Dunbar, C. E. (2001). Update on the use of nonhuman primate models for preclinical testing of gene therapy approaches targeting hematopoietic cells. Hum. Gene Ther. 12: 607-617.
38. Jakob, T., Walker, P. S., Krieg, A. M,, Udey, M. C., and Vogel, J. C. (1998). Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161: 3042-3049.
39. Sykes, M. (1996). Hematopoietic cell transplantation for the induction of allo- and xenotolerance. Clin. Transplant. 10: 357-363.
40. Wekerle, T., and Sykes, M. (2001). Mixed chimerism and transplantation tolerance. Annu. Rev. Med. 52: 353-370.
41. Clave, E., et al. (1995). Multicolor flow cytometry analysis of blood cell subsets in patients given total body irradiation before bone marrow transplantation. Int. J. Radiat. Oncol. Biol. Phys. 33: 881-886.
42. Wekerle, T., Kurtz, J., Bigenzahn, S., Takeuchi, Y., and Sykes, M. (2002). Mechanisms of transplant tolerance induction using costimulatory blockade. Curr. Opin. Immunol. 14: 592-600.
43. + cells. Blood 88: 4166-4172.
44. Amara, R. R., et al. (2002). Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines. J. Virol. 76: 7625-7631.
45. Letvin, N. L., et al. (1997). Potent, protective anti-HIV immune responses generated by bimodal HTV envelope DNA plus protein vaccination. Proc. Natl. Acad. Sci. USA 94: 9378-9383.